Loading clinical trials...
Loading clinical trials...
A Randomised, Double-blind, Double-dummy, Parallel-group, Multicenter, Phase IIb Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing the Number of Days With Pain in Young Adults With Sickle Cell Disease
Conditions
Interventions
Ticagrelor
Placebo
Locations
20
United States
Research Site
Miami, Florida, United States
Research Site
Bethesda, Maryland, United States
Research Site
Charleston, South Carolina, United States
Research Site
Alexandria, Egypt
Research Site
Cairo, Egypt
Research Site
Cairo, Egypt
Start Date
July 9, 2015
Primary Completion Date
November 16, 2016
Completion Date
November 16, 2016
Last Updated
December 19, 2018
NCT05170412
NCT06526117
NCT06665997
NCT07431398
NCT07222475
NCT05377372
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions